| Identification | Back Directory | [Name]
BOC-LEU-GLY-OH | [CAS]
32991-17-6 | [Synonyms]
BOC-LEU-GLY-OH
Boc-L-Leu-Gly-OH
Boc-Leu-Gly-OH≥ 99% (TLC)
(Tert-Butoxy)Carbonyl Leu-Gly-OH
tert-(Butyloxycarbonyl)leucylglycine
(tert-Butoxycarbonyl)-L-leucylglycine
N-(tert-Butoxycarbonyl)-L-leucylglycine
N-[(1,1-Dimethylethoxy)carbonyl]-L-leucylglycine
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl-
(S)-2-(2-((tert-Butoxycarbonyl)aMino)-4-MethylpentanaMido)acetic acid
2-[(2S)-2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanamido]acetic acid
2-[[(2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]amino]acetic acid | [Molecular Formula]
C13H24N2O5 | [MDL Number]
MFCD00076954 | [MOL File]
32991-17-6.mol | [Molecular Weight]
288.34 |
| Chemical Properties | Back Directory | [Boiling point ]
499.6±30.0 °C(Predicted) | [density ]
1.122±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [pka]
3.42±0.10(Predicted) |
| Hazard Information | Back Directory | [Chemical Properties]
White powder | [Uses]
N-[N-[(1,1-Dimethylethoxy)carbonyl]-L-leucyl]-glycine is used to prepare aziridinedicarboxylic acid peptides as cysteine protease inhibitors. It is also used to prepare dipeptide monoester prodrugs of floxuridine with enhanced cancer cell growth inhibition. |
|
|